Annovis Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ANVS New York 8731 https://www.annovisbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Annovis Bio Inc

Avidity (RNA) Down on Update From Neuromuscular Disease Study - Mar 31st, 2023 3:44 pm
Here's Why Momentum in Annovis Bio, Inc. (ANVS) Should Keep going - Mar 30th, 2023 12:50 pm
Intra-Cellular (ITCI) Depression Drug Meets Study Goal, Stock Up - Mar 29th, 2023 4:27 pm
Bicycle (BCYC) up on Collaboration With Novartis for Conjugates - Mar 29th, 2023 12:17 pm
Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug - Mar 28th, 2023 2:41 pm
Are Medical Stocks Lagging Annovis Bio (ANVS) This Year? - Mar 28th, 2023 1:40 pm
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Mar 27th, 2023 4:09 pm
ANNOVIS BIO ANNOUNCES TWO PRESENTATIONS AT THE AD/PD™ 2023 INTERNATIONAL CONFERENCE ON ALZHEIMER'S AND PARKINSON'S DISEASES - Mar 22nd, 2023 11:30 am
COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar - Mar 21st, 2023 3:24 pm
Deciphera (DCPH) Gets Breakthrough Tag for Qinlock Expanded Use - Mar 15th, 2023 3:52 pm
Mirum's (MIRM) Livmarli Gets FDA Nod for Expanded Use, Stock Up - Mar 15th, 2023 1:05 pm
Seagen (SGEN) Set to be Acquired by Pfizer for $43 B, Stock Up - Mar 14th, 2023 1:06 pm
Acadia (ACAD) Gets FDA Approval for Daybue for Rett Syndrome - Mar 13th, 2023 2:19 pm
Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year? - Mar 8th, 2023 2:40 pm
While insiders own 32% of Annovis Bio, Inc. (NYSE:ANVS), individual investors are its largest shareholders with 58% ownership - Feb 17th, 2023 2:59 pm
Wall Street Analysts Believe Annovis Bio, Inc. (ANVS) Could Rally 152.89%: Here's is How to Trade - Feb 17th, 2023 2:55 pm
Is Annovis Bio (ANVS) Stock Outpacing Its Medical Peers This Year? - Feb 17th, 2023 2:40 pm
Lab Notes: Center for Breakthrough Medicines expands offerings; Researchers identify key 'gene signature' - Feb 10th, 2023 6:36 pm
Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease - Feb 8th, 2023 12:30 pm
Does Annovis Bio, Inc. (ANVS) Have the Potential to Rally 178.45% as Wall Street Analysts Expect? - Feb 1st, 2023 2:55 pm